Cancer In Norway 2024

Key message

20 623 (53.1%) of the cases occurred among males, and 18 188 (49.9%) were diagnosed among females.

The five most frequent types of cancer in males and females (measured as average annual number of new cases) in 2020–2024 are listed below.

These cancers accounted for 57.4% of all cancers in males and 57.1% of all cancers in females.

Males:

• Prostate cancer
• Lung cancer
• Non-melanoma skin cancer
• Colon cancer
• Melanoma of the skin

Females:

• Breast cancer
• Colon cancer
• Lung cancer
• Non-melanoma skin cancer
• Melanoma of the skin

When comparing the combined incidence rates for all cancer sites in the last five-year period (2020–2024) with the previous one (2015–2019), we observe that the rate has decreased in males (-4%) while a slight increase has occurred in females (2%).

There has also been a decline in rates for many cancer sites. Particularly noticeable reductions are seen for lung, prostate and testicular cancer in males, and for cervical, ovarian and uterine cancer in females.

The largest decrease in incidence rate is observed for cervical cancer (-17.2%), and the rate observed in 2024 is the lowest ever reported in Norway.

The aim of the annual publication of Cancer in Norway (CiN) is to provide detailed cancer statistics. This publication should help health professionals, policy-makers and researchers to identify and make decisions about areas that need more attention and investigation.

This publication may also be valuable for the media, educators and members of the public with an interest in cancer.